â‚©
4480.00
Nov 29
Business Description
Dongsung Pharmaceutical Co Ltd
ISIN : KR7002210003
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | 0.31 | |||||
Debt-to-Equity | 1.43 | |||||
Debt-to-EBITDA | -648.33 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | 1.42 | |||||
Beneish M-Score | -2.38 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.5 | |||||
3-Year EPS without NRI Growth Rate | 29.9 | |||||
3-Year FCF Growth Rate | -46.9 | |||||
3-Year Book Growth Rate | -9.4 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 62.49 | |||||
9-Day RSI | 54.55 | |||||
14-Day RSI | 50.5 | |||||
6-1 Month Momentum % | -12.15 | |||||
12-1 Month Momentum % | -27.84 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.97 | |||||
Quick Ratio | 0.66 | |||||
Cash Ratio | 0.01 | |||||
Days Inventory | 152.37 | |||||
Days Sales Outstanding | 127.95 | |||||
Days Payable | 84.3 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.8 | |||||
Shareholder Yield % | -9.14 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 44.36 | |||||
Operating Margin % | -3.68 | |||||
Net Margin % | -5.33 | |||||
FCF Margin % | -8.54 | |||||
ROE % | -11.93 | |||||
ROA % | -3.91 | |||||
ROIC % | -4.39 | |||||
ROC (Joel Greenblatt) % | -3.06 | |||||
ROCE % | -3.44 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.22 | |||||
PB Ratio | 2.76 | |||||
Price-to-Tangible-Book | 2.82 | |||||
EV-to-EBIT | -72.04 | |||||
EV-to-EBITDA | -1896.63 | |||||
EV-to-Revenue | 1.76 | |||||
EV-to-FCF | -20.53 | |||||
Price-to-Median-PS-Value | 0.67 | |||||
Earnings Yield (Greenblatt) % | -1.39 | |||||
FCF Yield % | -7.3 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Dongsung Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 87,627.615 | ||
EPS (TTM) (â‚©) | -204 | ||
Beta | 0.24 | ||
Volatility % | 12.34 | ||
14-Day RSI | 50.5 | ||
14-Day ATR (â‚©) | 107.661969 | ||
20-Day SMA (â‚©) | 4471.75 | ||
12-1 Month Momentum % | -27.84 | ||
52-Week Range (â‚©) | 4255 - 6310 | ||
Shares Outstanding (Mil) | 22.87 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Dongsung Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Dongsung Pharmaceutical Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Dongsung Pharmaceutical Co Ltd Frequently Asked Questions
What is Dongsung Pharmaceutical Co Ltd(XKRX:002210)'s stock price today?
When is next earnings date of Dongsung Pharmaceutical Co Ltd(XKRX:002210)?
Does Dongsung Pharmaceutical Co Ltd(XKRX:002210) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |